J
Ji Eun Lee
Researcher at Inha University
Publications - 224
Citations - 2199
Ji Eun Lee is an academic researcher from Inha University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 200 publications receiving 1691 citations. Previous affiliations of Ji Eun Lee include University of Utah & Samsung.
Papers
More filters
Journal ArticleDOI
2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)
Kwang-Il Kim,Myung A. Kim,Min Kyung Kim,Sang-Hyun Kim,Hyo-Soo Kim,Min Kyong Moon,Kyong Soo Park,Young-Bae Park,Soo Lim,Sung Hee Choi,Hae Young Lee,Hak Chul Jang,Sang Hak Lee,Donghoon Choi,Hyun Cheol Lee,Hyeon Chang Kim,Sun Ha Jee,Hyun Taek Cheong,Joong-Yeol Park,Chang Hee Jung,Mun-Kyu Lee,Eun-Jung Rhee,Kim Do Kyung,Eun Mi Kim,Soon Jun Hong,Soon Cheol Hong,Young Seol Kim,Woo Sik Kim,You-Cheol Hwang,Kyu Jeong Ahn,Young-Mi Kim,Seong-Cheol Chae,Yeo-Min Yun,Yangha Kim,Jung Park,Yong Jae Kim,Jin Han,Jongwoo Kim,Youngjoo Kim,Sung-Rae Kim,Sang Hong Baek,Hyuk-Sang Kwon,YoonJu Song,Hyunwook Kim,Moon Suk Nam,Sung Hee Shin,Ji Eun Lee,Jaetaek Kim,Chee Jeong Kim,Dae Jung Kim,Oh Yoen Kim,Jae-Ryong Kim,Kyung-Hyun Cho,Yongsoon Park,Gi Ho Song,Hyun-Ho Shin,Youngkeun Ahn,Young Joon Hong,Myoungsook Lee,Sae Young Jae,Sang-Ho Jo,Seonghoon Choi,Young Jin Choi,Hyun Young Park,Kyungwon Oh,Ki Man Ahn,Comm Korean Guidelines Manage +66 more
TL;DR: This guideline is translated from “J Lipid Atheroscler 2015;4(1):61-92” and the authors have no financial conflicts of interest.
Journal ArticleDOI
Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models
Jae Hun Shin,Hyung Bae Park,Yu Mi Oh,Dong Pyo Lim,Ji Eun Lee,Hae Hyun Seo,Sang-Jin Lee,Hyeon Seok Eom,In Hoo Kim,Seunghoon Lee,Kyungho Choi +10 more
TL;DR: A novel CTLA4 mutant that could be expressed in tumor antigen-specific T cells to enhance antitumor effect without systemic autoimmunity is developed and the gene modification of CD8 T cells along with CD4 T cells further maximized antitumors effect of T cells in 2 different murine tumor models.
Journal ArticleDOI
Hematuria and proteinuria in a mass school urine screening test.
Yong Hoon Park,Jung Youn Choi,Hyo Seok Chung,Ja Wook Koo,Su Yung Kim,Mee Kyung Namgoong,Young Seo Park,Kee Hwan Yoo,Kyung-Yil Lee,Dae Yeol Lee,Seung Joo Lee,Ji Eun Lee,Woo Yeong Chung,Tae Sun Hah,Hae Il Cheong,Yong Choi,Kyung Soo Lee +16 more
TL;DR: This study showed that the use of a mass school urine screening program can detect chronic renal disease in its early stage and recommends that more attention should be paid to identifying those children with CHP and massive proteinuria.
Journal ArticleDOI
Effect of Helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection
TL;DR: Adolescent girls with sideropenic refractory anaemia should be evaluated for H. pylori infection if it is coexistent, and its eradication along with iron supplementation could correct the anaemia.
Journal ArticleDOI
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Jeffrey S. Heier,Carlos Quezada Ruiz,Karen Basu,Christopher Brittain,Marta S. Figueroa,Hugh Lin,Frank G. Holz,Vaibhavi Patel,Timothy Y Y Lai,David Silverman,Carl D. Regillo,Balakumar Swaminathan,Francesco Viola,Chui Ming Gemmy Cheung,Tien Yin Wong,Ashkan M. Abbey,E.B.K Abdulaeva,Prema Abraham,Alfredo Adan Civera,Hansjürgen Agostini,Arturo Alezzandrini,Virgil Alfaro,Arghavan Almony,Lebriz Altay,Payam Amini,Andrew N. Antoszyk,Etelka Aradi,Luis Arias,Jennifer J. Arnold,R H Y Asaria,Sergei Y. Astakhov,Yury S. Astakhov,Carl C. Awh,Chandrakumar Balaratnasingam,Sanjiv Banerjee,Caroline R. Baumal,Matthias D. Becker,Rubens Belfort,G.V. Bratko,William Jr. Z Bridges,Jamin S. Brown,David M. Brown,M.V. Budzinskaya,S. Buffet,Stuart C Burgess,Ik Soo Byon,Carlo Cagini,Jorge I. Calzada,S. Cameron,Peter A. Campochiaro,John Carlson,Angela Carneiro,Clement K. Chan,Emmanuel Chang,Andrew Chang,Daniel Chao,Nauman A Chaudhry,Caroline Chee,Andrew G. Cheek,Shih-Jen Chen,Sanford Chen,Gemmy Cheung,Saradha Chexal,Mark Chittum,David Chow,Abosede Cole,Brian P Connolly,Pierre-Loïc Cornut,Stephen Couvillion,Carl J. Danzig,Vesselin Daskalov,Amr Dessouki,F. Devin,Michael Dollin,R. Dolz,Lois Downey,Richard F. Dreyer,Pravin U. Dugel,David A Eichenbaum,Bora Eldem,R. O. Y. Engstrom,J. J. Escobar,Nicole Eter,David Faber,Naomi S. Falk,Leonard Feiner,Alvaro Fernandez Vega,Philip J. Ferrone,Marta Amaral Figueroa,Howard I. Fine,Mitchell S. Fineman,Gregory M. Fox,Catherine Français,Pablo Franco,Samantha Fraser-Bell,Nicholas S.K. Fung,Federico Sola,Richard O. Gale,Alfredo García-Layana,Julie Gasperini,Maciej Gawęcki,Faruque Ghanchi,Manjot K. Gill,Michael Joseph Giunta,D. Glaser,Michael B. Goldstein,Francisco Gomez Ulla,Fumi Gomi,Víctor González,Jordan M. Graff,Sunil Gupta,Rainer Guthoff,Robyn H. Guymer,Anton Haas,Robert Tudor. Hampton,Katja Hatz,Ken Hayashi,Ewa Herba,Vrinda S. Hershberger,Patrick Higgins,Nancy M. Holekamp,Shigeru Honda,James Andrew Howard,Allen Hu,Stephen M. Huddleston,Tomohiro Iida,Hiroko Imaizumi,Yasuo Ito,Yasuki Ito,Sujit Itty,Golnaz Javey,Cameron Javid,Tatsushi Kaga,Jakub J. Kaluzny,Se Woong Kang,Kapil Kapoor,Levent Karabaş,Tsutomu Kawasaki,Patrick J. Kelty,Ágnes Kerényi,Arshad M. Khanani,Ramin Khoramnia,Rahul N. Khurana,Kazuhiro Kimura,Kendra Klein-Mascia,Namie Kobayashi,Laurent Kodjikian,Hideki Koizumi,Gregg T. Kokame,Alexey Kulikov,Henry Kwong,R. Kwun,Chi-Chun Lai,L Lalonde,Paolo Lanzetta,Michael Larsen,Adrian M. Lavina,Won Ki Lee,Ji Eun Lee,Seong Cheol Lee,Jaim Atri Levy,Luke B. Lindsell,Mimi Liu,N.J. London,Andrew J. Lotery,D. Lozano Rechy,Alan Luckie,David Maberley,Takatoshi Maeno,Sajjad Mahmood,Fuad Makkouk,Dennis M. Marcus,Alan R. Margherio,H. Masse,Hisashi Matsubara,Raj K. Maturi,Sonia Mehta,Geeta Menon,Jale Menteş,Mark Michels,Yoshinori Mitamura,Paul Mitchell,Quresh Mohamed,Jordi Monés,Rodrigo Montemayor Lobo,Javier Montero,Jeffrey Thomas Moore,Ryusaburo Mori,Haia Morori-Katz,Raj Mukherjee,Toshinori Murata,Maria Muzyka-Woźniak,Marco Nardi,Nirodhini Narendran,Massimo Nicolò,Jared S. Nielsen,Tetsuya Nishimura,Kousuke Noda,Anna Nowińska,Hideyasu Oh,Matthew Ohr,Annabelle A. Okada,Piotr Oleksy,Shinji Ono,Sengul Ozdek,Banu Ozturk,Luisito S. Pablo,Kyu Hyung Park,Darrel W. Parke,Mariacristina Parravano,Praveen J Patel,Apurva Patel,Sunil S. Patel,Sugat Patel,Daniel Pauleikhoff,Ian Pearce,Joel Pearlman,Iva Petkova,Dante J. Pieramici,N. A. Pozdeyeva,Jawad Qureshi,Dorota Raczyńska,Juan Abel Ramírez Estudillo,R Rathod,Hessamoddin Meshkat Razavi,Gayatri Reilly,Federico Ricci,Ryan M. Rich,Bożena Romanowska-Dixon,Irit Rosenblatt,José María Moreno,Stefan Sacu,Habiba Saedon,Usman Saeed,Min Sagong,Taiji Sakamoto,Sukhpal S Sandhu,Laura Sararols,Mario Saravia,Ramin Schadlu,Patricio G. Schlottmann,Tetsuju Sekiryu,Andras Seres,Figen Şermet,Sumit P Shah,Rohan Shiloh Shah,Ankur S. Shah,Tom G. Sheidow,Veeral S. Sheth,Chieko Shiragami,Bartosz L. Sikorski,Rufino Silva,Lawrence J. Singerman,R. C. Sisk,Torben Lykke Sørensen,Eric H Souied,David J. Spinak,Giovanni Staurenghi,Robert R. Steinmetz,Glenn L. Stoller,Robert E. Stoltz,Eric P. Suan,Ivan J. Suñer,Y. O'Reilly Suzanne,Ramin Tadayoni,Kanji Takahashi,Kenji Takayama,Alexandre Chater Taleb,James S Talks,Hiroko Terasaki,John Thompson,Edit Tóth-Molnár,Khoi Tran,Raman Tuli,E. Uchiyama,Attila Vajas,Janneke Van Lith-Verhoeven,Balázs Varsányi,Gianni Virgili,Gábor Vogt,Michael Völker,David Warrow,Pamela Weber,John A. Wells,Sanjeewa S. Wickremasinghe,Mark R. Wieland,Geoff Williams,Thomas Williams,David Wong,King Chong. Wong,James Wai Keat Wong,Ian Y. H. Wong,Robert Kin Ming Wong,Bogumil Wowra,Charles C. Wykoff,Ayana Yamashita,Kanako Yasuda,Gürsel Yilmaz,Glenn Yiu,Ai Yoneda,Young Hee Yoon,Barak Yoreh,HyeongGon Yu,Seung-Young Yu,Tatiana S. Yurieva,Alberto Zambrano,Barbara Zatorska,C. Zeolite +307 more
TL;DR: Visual benefits with faricimab given at up to 16-week intervals demonstrates its potential to meaningfully extend the time between treatments with sustained efficacy, thereby reducing treatment burden in patients with nAMD.